微RNA与冠状动脉疾病研究的文献计量学评价
Bibliometric review of microRNA and coronary artery disease
李敏 1赵小晗 2刘敏 2马晓娟1
作者信息
- 1. 中国中医科学院西苑医院心血管科,北京 100091
- 2. 北京中医药大学研究生院,北京 100029
- 折叠
摘要
目的 基于CiteSpace和VOSviewer探讨微RNA(miRNA)与冠状动脉疾病(CAD)研究的热点与趋势.方法 通过检索Web of Science核心合集数据库和中国知网、万方数据知识服务平台、维普网,获取 2010 年 1 月至 2023 年 6月有关miRNA与CAD研究的相关文献,利用CiteSpace 6.2.R2、VOSviewer 1.6.19 绘制作者、关键词共现、突现、时间线图谱.结果 共纳入英文文献 1 733 条,中文文献 748 条.中国是最高产的国家,中山大学是领先的研究机构,王阶发表论文最多.冠心病、动脉粥样硬化是主要关键词.结论 验证不同miRNA亚型对CAD的调控作用及其机制为主要热点,未来的研究将致力于促进miRNA在CAD早期诊断、治疗及预后中的临床应用.
Abstract
Objective To explore the research hotspot and trend of microRNA(miRNAS)and coronary artery disease(CAD)based on CiteSpace and VOSviewer.Methods Web of Science core collection database and China National Knowledge Network,Wanfang Data,VIP were searched,and the relevant literatures on miRNA and CAD studies from January 2010 to June 2023 was obtained.CiteSpace 6.2.R2 and VOSviewer 1.6.19 were used to draw author,keyword co-occurrence,emergence and time line maps.Results A total of 1 733 English literatures and 748 Chinese literatures were included.China is the most productive country,Sun Yat-sen University as the leading research institution,and Wang Jie has published the most papers.Coronary heart disease and atherosclerosis were the main keywords.Conclusion The main focus is to verify the regulatory effects and mechanisms of different miRNA subtypes on CAD.Future studies will be devoted to promoting the clinical application of miRNA in early diagnosis,treatment and prognosis of CAD.
关键词
微RNA/冠状动脉疾病/CiteSpace/VOSviewerKey words
microRNA/Coronary artery disease/CiteSpace/VOSviewer引用本文复制引用
基金项目
国家自然科学基金资助项目(82074418)
中国中医科学院科技创新工程重大攻关项目(CI2021A00911)
出版年
2024
NETL
NSTL
万方数据